1-4 of 4
P.A. Von Dem Borne, MD, PhD
Close
Sort by
Journal Articles

In Vivo T Cell Depletion Using Rabbit Derived ATG Leads to An Increased EBV-PTLD Risk Due to An Induced Imbalance Between B and T Cell Recovery Which Is Not Seen After Horse Derived ATG or Alemtuzumab

C.J.M. Halkes, MD, PhD, J.H.F. Falkenburg, MD, PhD, H.M. van Egmond, J. Olde Wolbers, C.W.J. Starrenburg, P. van Balen, MD, M. van de Meent, P.A. von dem Borne, MD, PhD, W.A.F. Marijt, MD, PhD, J.H. Veelken, MD, PhD, I Jedema, PhD
Journal: Blood
Blood (2011) 118 (21): 1979.
https://doi.org/10.1182/blood.V118.21.1979.1979
Published: 2011
Journal Articles

Long-Term Disease-Free Survival of Patients with AML Relapse After T-Cell-Depleted Allogeneic Stem Cell Transplantation by Re-Induction Therapy and Subsequent Interferon-Boosted Donor Lymphocyte Infusion

M. Eefting, MD, C.J.M. Halkes, MD, PhD, S. Kersting, MD, PhD, W.A.F. Marijt, MD, PhD, P.A. von dem Borne, MD, PhD, J.H. Veelken, MD, PhD, J.H.F. Falkenburg, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 3064.
https://doi.org/10.1182/blood.V118.21.3064.3064
Published: 2011
Journal Articles

Post-Transplant Immune Suppressive Therapy Is Not Necessary In Related and Unrelated Reduced Intensity Conditioning Stem Cell Transplantation Using Low Dose Alemtuzumab In Vivo T Cell Depletion Combined with Alemtuzumab-Mediated In Vitro T Cell Depletion of the Graft

P.A. Von Dem Borne, MD, PhD, C.J.M. Halkes, MD, PhD, C.W.J. Starrenburg, W.A.F. Marijt, MD, PhD, J.H.F. Falkenburg, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2328.
https://doi.org/10.1182/blood.V116.21.2328.2328
Published: 2010
Journal Articles

Retroviral Interference with Execution Pathways in Target Cells To Unravel Mechanisms of Cytotoxic T Cell-Mediated Cell Death.

J.F. de Vries, MSc, P.A. von dem Borne, MD, PhD, M.H.M. Heemskerk, PhD, R. Willemze, MD, PhD, J.H.F. Falkenburg, MD, PhD, R.M.Y. Barge, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 1267.
https://doi.org/10.1182/blood.V104.11.1267.1267
Published: 2004